Asset Details
Do you wish to reserve the book?
Comparison of olopatadine with ketotifen for allergic conjunctivitis: a meta-analysis study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Comparison of olopatadine with ketotifen for allergic conjunctivitis: a meta-analysis study
Do you wish to request the book?
Comparison of olopatadine with ketotifen for allergic conjunctivitis: a meta-analysis study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Comparison of olopatadine with ketotifen for allergic conjunctivitis: a meta-analysis study
2023
Overview
Allergic conjunctivitis is one of the most common non-traumatic extraocular inflammatory diseases.
The comparison of olopatadine with ketotifen remains elusive for the treatment of allergic conjunctivitis, and this meta-analysis aims to explore the impact of olopatadine versus ketotifen on treatment efficacy for allergic conjunctivitis.
PubMed, Embase, Web of Science, EBSCO, and Cochrane library databases were systematically searched, and we included randomized controlled trials (RCTs) assessing the effect of olopatadine versus ketotifen on efficacy in patients with allergic conjunctivitis. Seven RCTs were included in the meta-analysis.
Overall, compared with ketotifen intervention for allergic conjunctivitis, olopatadine intervention was associated with substantially lower hyperaemia (mean difference (MD) = -0.77; 95% confidence interval (CI) = -1.24 to -0.30;
= 0.001), but demonstrated no significant impact on itching, tearing or papillae.
These suggested that olopatadine may be more effective to relieve the symptoms of allergic conjunctivitis than ketotifen.
Publisher
Termedia Publishing House
Subject
